The Studies. Investigator-Sponsor, who is employed by MSK, has been and wishes to continue to conduct at MSK, a clinical study which will be set forth in a separate clincial study addendum which shall be signed by the parties hereto, acknowledged by the Investigator-Sponsor, and shall contain terms in a form set forth in the template contained in Appendix A (“Study Addendum”). Each Study Addendum shall specify the study product to be supplied by Company for each Study (the “Study Drug Products”) under the protocol specified in the Study Addendum, and amended from time to time (such clinical studies are hereinafter referred to as the “Studies” and each protocol is hereinafter a “Protocol”). Company is willing to supply the Study-support funding specified in Section 3 and further described in each Study Addendum (the “Funding”), and MSK, through the Investigator-Sponsor, agrees to conduct the Study under the terms and conditions set forth in this Agreement and each Study Addendum.
Appears in 2 contracts
Sources: Investigator Sponsored Master Clinical Trial Agreement (Y-mAbs Therapeutics, Inc.), Master Clinical Trial Agreement (Y-mAbs Therapeutics, Inc.)